“…Second, this line of research became well accepted to study brain functions related to schizophrenia free from confounding correlates of severe clinical symptoms such as medication and institutionalization (eg Gooding et al, 1999;Avons et al, 2003). In fact, preselected and unselected schizotypal individuals, thought to be 'psychosis-prone' (Chapman et al, 1994;Kwapil et al, 1997), perform similar to patients with schizophrenia for cognitive (Gooding et al, 1999;Park, 1999), attentional (Sarkin et al, 1998;Mohr et al, 2003a), behavioral (Barnett and Corballis, 2002;Mohr et al, 2003b) and physiological (Klein et al, 1999;Pizzagalli et al, 2000) measures. Finally, alterations of dopaminergic responsivity may accompany the schizophrenia spectrum disorders in a continuous manner; the DA metabolite homovanillin acid (HVA) correlated with severity of positive symptoms in schizophrenia (Pickar et al, 1984;Davidson and Davis, 1988) and the extent of schizotypal personality disorder (Siever et al, 1991(Siever et al, , 1993.…”